Substituted 1-methyl-4-phenylpyrrolidin-2-ones - Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors

被引：7

作者：

Hilton-Proctor, J. P. ^{[1
]}

Ilyichova, O. ^{[1
]}

Zheng, Z. ^{[1
]}

Jennings, I. G. ^{[1
]}

Johnstone, R. W. ^{[2
,3
]}

Shortt, J. ^{[4
,5
]}

Mountford, S. J. ^{[1
]}

Scanlon, M. J. ^{[1
]}

Thompson, P. E. ^{[1
]}

机构：

[1] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic, Australia

[2] Peter MacCallum Canc Ctr, 305 Grattan St, Melbourne, Vic, Australia

[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia

[4] Monash Univ, Monash Hlth, Sch Clin Sci, Blood Canc Therapeut Lab, 246 Clayton Rd, Clayton, Vic, Australia

[5] Monash Hlth, Monash Haematol, 246 Clayton Rd, Clayton, Vic, Australia

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 191卷

关键词：

BRD4; Bromodomain; Epigenetics; K-ac; Fragment-based Drug Design; CHEMICAL PROBE; PHD FINGER; DISCOVERY; OPTIMIZATION; CONSTRUCTION; LIGANDS;

D O I：

10.1016/j.ejmech.2020.112120

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

N-Methylpyrrolidone is one of several chemotypes that have been described as a mimetic of acetyl-lysine in the development of bromodomain inhibitors. In this paper, we describe the synthesis of a 4-phenyl substituted analogue - 1-methyl-4-phenylpyrrolidin-2-one - and the use of aryl substitution reactions as a divergent route for derivatives. Ultimately, this has led to structurally complex, chiral compounds with progressively improved affinity as inhibitors of bromodomain-containing protein 4. (c) 2020 Elsevier Masson SAS. All rights reserved.

引用

页数：17

共 55 条

[1] Towards automated crystallographic structure refinement with phenix.refine [J].

Afonine, Pavel V. ;

Grosse-Kunstleve, Ralf W. ;

Echols, Nathaniel ;

Headd, Jeffrey J. ;

Moriarty, Nigel W. ;

Mustyakimov, Marat ;

Terwilliger, Thomas C. ;

Urzhumtsev, Alexandre ;

Zwart, Peter H. ;

Adams, Paul D. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2012, 68 :352-367

[2] A Chemical Probe for the ATAD2 Bromodomain [J].

Bamborough, Paul ;

Chung, Chun-wa ;

Demont, Emmanuel H. ;

Furze, Rebecca C. ;

Bannister, Andrew J. ;

Che, Ka Hing ;

Diallo, Hawa ;

Douault, Clement ;

Grandi, Paola ;

Kouzarides, Tony ;

Michon, Anne-Marie ;

Mitchell, Darren J. ;

Prinjha, Rab K. ;

Rau, Christina ;

Robson, Samuel ;

Sheppard, Robert J. ;

Upton, Richard ;

Watson, Robert J. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (38) :11382-11386

[3] iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM [J].

Battye, T. Geoff G. ;

Kontogiannis, Luke ;

Johnson, Owen ;

Powell, Harold R. ;

Leslie, Andrew G. W. .

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2011, 67 :271-281

[4] Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors [J].

Bennett, Michael J. ;

Wu, Yiqin ;

Boloor, Amogh ;

Matuszkiewicz, Jennifer ;

O'Connell, Shawn M. ;

Shi, Lihong ;

Stansfield, Ryan K. ;

Del Rosario, Joselyn R. ;

Veal, James M. ;

Hosfield, David J. ;

Xu, Jiangchun ;

Kaldor, Stephen W. ;

Stafford, Jeffrey A. ;

Betancort, Juan M. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) :1811-1816

[5]

Brewer M., 2008, FRAGMENT BASED DRUG, P39

[6] Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors [J].

Casale, Elena ;

Amboldi, Nadia ;

Brasca, Maria Gabriella ;

Caronni, Dannica ;

Colombo, Nicoletta ;

Dalvit, Claudio ;

Felder, Eduard R. ;

Fogliatto, Gianpaolo ;

Galvani, Arturo ;

Isacchi, Antonella ;

Polucci, Paolo ;

Riceputi, Laura ;

Sola, Francesco ;

Visco, Carlo ;

Zuccotto, Fabio ;

Casuscelli, Francesco .

BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (15) :4135-4150

[7] Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay [J].

Chen, Zhifeng ;

Zhang, Hao ;

Liu, Shien ;

Xie, Yiqian ;

Jiang, Hao ;

Lu, Wenchao ;

Xu, Heng ;

Yue, Liyan ;

Zhang, Yuanyuan ;

Ding, Hong ;

Zheng, Mingyue ;

Yu, Kunqian ;

Chen, Kaixian ;

Jiang, Hualiang ;

Luo, Cheng .

MEDCHEMCOMM, 2017, 8 (06) :1322-1331

[8] Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery [J].

Chung, Chun-wa ;

Dean, Anthony W. ;

Woolven, James M. ;

Bamborough, Paul .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) :576-586

[9] 19F NMR isotropic chemical shift for efficient screening of fluorinated fragments which are racemates and/or display multiple conformers [J].

Dalvit, Claudio ;

Knapp, Stefan .

MAGNETIC RESONANCE IN CHEMISTRY, 2017, 55 (12) :1091-1095

[10] Elucidation of a Structural Basis for the Inhibitor-Driven, p62 (SQSTM1)-Dependent Intracellular Redistribution of cAMP Phosphodiesterase-4A4 (PDE4A4) [J].

Day, Jonathan P. ;

Lindsay, Barbara ;

Riddell, Tracy ;

Jiang, Zhong ;

Allcock, Robert W. ;

Abraham, Achamma ;

Sookup, Sebastian ;

Christian, Frank ;

Bogum, Jana ;

Martin, Elisabeth K. ;

Rae, Robert L. ;

Anthony, Diana ;

Rosair, Georgina M. ;

Houslay, Daniel M. ;

Huston, Elaine ;

Baillie, George S. ;

Klussmann, Enno ;

Houslay, Miles D. ;

Adams, David R. .

JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) :3331-3347

← 1 2 3 4 5 6 →